1. Schwartz A, Pashko L: Mechanism of cancer prevention action of DHEA. Ann NY Acad Sci. 1995, 774: 180-186.
2. Bullbrock RD, Hayward JL, Spicer CC: Relation between urinary androgen and corticoid excretion and subsequent breast cancer. Lancet. 1971, 2: 395-398. 10.1016/S0140-6736(71)90113-9.
3. Dorgan JF, Stanczyk FZ, Longscope C, Stephenson HE, Chang L, Miller R, Franz C, Falk RT, Kahle L: Relationship of serum dehydroepiandrosterone (DHEA) dehydroepiandrosterone sulfate and 5-androstene-β, 17-β-diol to risk of breast cancer in postmenopausal women. Cancer Epidemiol Biomark Prev. 1997, 6: 177-181.
4. Ratko TA, Detrisac CJ, Mehta RG, Kelloff GJ, Moon RC: Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepindrosterone or a fluorinated analogue dehydroepiandrosterone. Cancer Res. 1991, 51: 481-486.
5. Li S, Yan XX, Belanger A, Labrie F: Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by DMBA in the rat. Breast Cancer Res Treat. 1994, 29: 203-217. 10.1007/BF00665681.